Abiraterone vs Enzalutamide + Radiation - Advanced Prostate...

Advanced Prostate Cancer

22,277 members27,978 posts

Abiraterone vs Enzalutamide + Radiation

PhilipSZacarias profile image
10 Replies

I would like to solicit the valued opinion of members of the HU community regarding the potential benefits of abiraterone or enzalutamide when undergoing radiotherapy. It is well known that radiation therapy can elicit a beneficial immunogenic response (i.e., abscopal effect) and that concurrent ADT improves the outcomes further (I am presently on (Lupron). I will be undergoing SBRT for a T12 metastasis and commencing abiraterone before the radiation - as a general rule, multimodal therapy is better than mono modal. There are many reports on the beneficial effect of concurrent abiraterone when undergoing radiotherapy, but not many discussing enzalutamide. One of my oncologists suggested that either abiraterone or enzalutamide could be used but noted that prednisone must be taken with abiraterone, and it is well known that prednisone is immunosppressive. I was considering taking a short course of enzalutamide during radiotheray and then switching to abiraterone after a couple of months. The literature also indicates that the sequence abiraterone-->enzalutamide is more favourable then enzalutamide-->abiraterone, but these are in settings where failure has occurred in the first hormone therapy.

Your comments, are appreciated. Cheers, Phil

Written by
PhilipSZacarias profile image
PhilipSZacarias
To view profiles and participate in discussions please or .
Read more about...
10 Replies
Tall_Allen profile image
Tall_Allen

There is no known benefit to including either drug with met-directed therapy. However, you should probably be using one of them if you are metastatic anyway:

prostatecancer.news/2019/12...

Prednisone, in the amounts used with abiraterone, are not immunosuppressive - it only replaces the cortisol that abiraterone eliminates.

PhilipSZacarias profile image
PhilipSZacarias in reply toTall_Allen

Thank you Tall_Allen. The 5 mg dose is within the immunosuppressive range but it makes sense that it replaces the missing cortisol and therefore not likely to affect the immune system. Cheers, Phil

Tall_Allen profile image
Tall_Allen in reply toPhilipSZacarias

Yes, it is only immunosuppressive if there is cortisol produced by the adrenals already.

fmenninger profile image
fmenninger

I’m currently on a similar treatment program. Combo abi/Lupron with prednisone and 26 igimrt rad to lower disease burden. I have 10 more rads left and doing pre-aerobic exercise just before getting zapped as this may help in the rad treatment, based on clinical trials. My RO says go for it as it will it hurt the rad treatments and any exercise will help with rad fatigue.

Magnus1964 profile image
Magnus1964

The better way is to choose one, start it a month or so before radiation and stay with it though radiation and after.

curious-mind1 profile image
curious-mind1

Hi PhilipSZacarias my dad took enzalutamide before abiraterone when his cancer metastasized to his bones. Enzalutamide brough his PSA down over the course of 3 months, but he had the most severe, neurological side-effects from it, to the point where he stopped eating and was bed-ridden. Once that happened, he was switched to Zytiga, the side-effects were minimal in comparison (just rather extreme muscle loss over time), and Zytiga brought his PSA down to undetectable within 1 year. He ended taking Zytiga for 5 years, until his sudden death from a burst aneurysm.

So in summary, his experience was positive with both drugs, in the sense that they both worked, with Zytiga being the better by far.

Best,

Art

PhilipSZacarias profile image
PhilipSZacarias in reply tocurious-mind1

Thank you Curious-Mind1/Art

monte1111 profile image
monte1111

Good post. Well thought out. By a flip of the coin I went to Xtandi after chemo. It has worked well for 3 years. Some questions have no answers. Best of wishes. Flip that coin.

Scootman profile image
Scootman

I was on Xtandi for 4 months and had no success and was just prescribed xtiga yesterday with 5 mg of prednisone . Met with Radiology Oncologistist today he wanted to do radium but my other oncologists over road him stating that they want me to try the xtiga even though they did not think it would work. ( does not make sense to me}. So they are going to try and do the SBRT and he told me this is just for the pain not to try and treat the cancer.Frustrated I want something to try and stop cancer from spreading. I wish I had more info to give you . Scootman good luck

PhilipSZacarias profile image
PhilipSZacarias in reply toScootman

Hello Scootman, if you had a poor response to Xtandi then it is likely that the response to Zytiga (which has a different mechanism of action) may also be poor...but you never know with certainty, so still worthwhile to try. There are blood tests that test for the presence of the AR-V7, an androgen receptor variant, that can predict the efficacy of the drugs. If Zytiga fails then you can request docetaxel, if you never had it before, or cabazitaxel if have have. Request that the SBRT be performed with the intention to ablate. The radiation may stimulate the immune system due to the generation of cancer antigens and slow progression. Good luck as well. We all need it. Cheers, Phil

Not what you're looking for?

You may also like...

BAT & Abiraterone / Enzalutamide resensitization

BAT is bipolar androgen therapy. Men receive cyclic high-dose testosterone injections while on...
pjoshea13 profile image

Abiraterone or Enzalutamide in Advanced CRPC.

New study below. "We found weak evidence that enzalutamide {Xtandi} outperforms AA {abiraterone...
pjoshea13 profile image

Abiraterone and Enzalutamide Raise Metabolic, Cardiovascular Adverse Event Risks

Abiraterone was significantly associated with an 84% and 37% increased risk for a major or minor...

Statin use in advanced PCA with ADT or abiraterone/enzalutamide

New meta-analysis below [1]. Does statin use affect mortality when used with classic ADT or...
pjoshea13 profile image

Abiraterone/enzalutamide+PARP inhibitor better than abiraterone/enzalutamide alone for mCRPC, even without BRCA+

A new therapy may be approved next month for all men with mCRPC. Previously, PARP inhibitors were...
Tall_Allen profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.